Vaxil Bio Ltd. (TSXV:VXL)
Canada flag Canada · Delayed Price · Currency is CAD
0.1600
0.00 (0.00%)
At close: Aug 18, 2026

Vaxil Bio Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
0.490.52-0.18-0.25-0.58-0.99
Depreciation & Amortization
----00.03
Loss (Gain) From Sale of Investments
-0.61-0.61----
Stock-Based Compensation
--0.010.020.020.07
Other Operating Activities
-0.07-0.070.03---
Change in Accounts Receivable
-0.070.010.01-0.010.010.08
Change in Accounts Payable
0.01-0-0.06-0.32-0.18-0.28
Operating Cash Flow
-0.27-0.17-0.24-0.56-0.73-1.08
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Investing Activities
0.270.27-0.25---
Investing Cash Flow
0.270.27-0.25---

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------0.01
Net Debt Issued (Repaid)
------0.01
Issuance of Common Stock
0.130.13---1.82
Financing Cash Flow
0.130.13---1.81

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0---0.0100.01
Net Cash Flow
0.120.22-0.49-0.57-0.730.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
0.060.15-0.4-0.47-0.52-0.7
Unlevered Free Cash Flow
0.060.15-0.4-0.47-0.52-0.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.060-0.05-0.33-0.17-0.19